ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.171,93
-1,04%
S&P 500
5.505,00
-0,71%
Dow Jones
40.287,53
-0,93%
Euro vs US Dollar
1,08925
0,00%
Bitcoin
66.565,05
-0,23%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Danaher Corporation (DHR)

  7. Danaher Corporation (DHR) News

DHR

Danaher (DHR)

Danaher Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:DHR
DatumZeitQuelleÜberschriftSymbolFirma
17/07/202413h30PR Newswire (US)Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine DevelopmentNYSE:DHRDanaher Corporation
16/07/202413h30PR Newswire (US)Danaher Releases 2024 Sustainability ReportNYSE:DHRDanaher Corporation
11/07/202413h30PR Newswire (US)Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug ScreeningNYSE:DHRDanaher Corporation
09/07/202409h00PR Newswire (US)Beckman Coulter Introduces New Integrated Chemistry and Immunoassay AnalyzerNYSE:DHRDanaher Corporation
24/06/202422h30PR Newswire (US)Danaher Schedules Second Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
19/06/202413h30PR Newswire (US)Danaher appoints Julie Sawyer Montgomery to Executive Vice President for DiagnosticsNYSE:DHRDanaher Corporation
05/06/202413h00PR Newswire (US)Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence OfficerNYSE:DHRDanaher Corporation
09/05/202413h00PR Newswire (US)Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological DiagnosisNYSE:DHRDanaher Corporation
07/05/202422h45PR Newswire (US)Danaher to Present at Bank of America Securities Healthcare ConferenceNYSE:DHRDanaher Corporation
07/05/202422h15PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
03/05/202415h06PR Newswire (US)Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow CytometryNYSE:DHRDanaher Corporation
23/04/202412h00PR Newswire (US)Danaher Reports First Quarter 2024 ResultsNYSE:DHRDanaher Corporation
21/03/202421h15PR Newswire (US)Danaher Schedules First Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
27/02/202422h15PR Newswire (US)Danaher to Present at TD Cowen Health Care ConferenceNYSE:DHRDanaher Corporation
22/02/202422h15PR Newswire (US)Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction TargetsNYSE:DHRDanaher Corporation
21/02/202422h15PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
05/02/202413h30PR Newswire (US)Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug DevelopmentNYSE:DHRDanaher Corporation
30/01/202412h00PR Newswire (US)Danaher Reports Fourth Quarter and Full Year 2023 ResultsNYSE:DHRDanaher Corporation
09/01/202413h30PR Newswire (US)Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform SolutionNYSE:DHRDanaher Corporation
08/01/202422h57Dow Jones NewsDanaher Says 4Q Adjusted. Revenue to Fall by Less Than ForecastNYSE:DHRDanaher Corporation
08/01/202422h15PR Newswire (US)Danaher CEO to Comment on Financial PerformanceNYSE:DHRDanaher Corporation
02/01/202423h00PR Newswire (US)Danaher to Present at J.P. Morgan Healthcare ConferenceNYSE:DHRDanaher Corporation
21/12/202322h30PR Newswire (US)Danaher Schedules Fourth Quarter 2023 Earnings Conference CallNYSE:DHRDanaher Corporation
13/12/202322h06GlobeNewswire Inc.Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseNYSE:DHRDanaher Corporation
06/12/202313h30PR Newswire (US)Danaher Completes Acquisition of AbcamNYSE:DHRDanaher Corporation
05/12/202323h14Dow Jones NewsDanaher Cuts Quarterly Dividend to 24 CentsNYSE:DHRDanaher Corporation
05/12/202322h30PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
21/11/202322h15PR Newswire (US)Danaher to Present at Evercore ISI HealthCONx ConferenceNYSE:DHRDanaher Corporation
21/11/202320h22Dow Jones NewsDanaher on Track for Largest Percent Increase in Almost a Year -- Data TalkNYSE:DHRDanaher Corporation
31/10/202312h30PR Newswire (US)Danaher appoints Christopher Riley to Executive Vice President for BiotechnologyNYSE:DHRDanaher Corporation
 Showing the most relevant articles for your search:NYSE:DHR

Kürzlich von Ihnen besucht

NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
TG
D7G
Nel ASA
TG
BAYN
Bayer
NASDAQ
TSLA
Tesla
TG
RHM
Rheinmetall
COIN
ETHUSD
Ethereum
AMEX
SPY
SPDR S&P 500
DBI
TDXP
Tec DAX
NYSE
NKE
Nike
NYSE
XOM
Exxon Mobil
TG
DBK
Deutsche Bank
CCOM
SILVER
SILVER
TG
ALV
Allianz
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten